Literature DB >> 25366932

Amyopathic dermatomyositis: definitions, diagnosis, and management.

Elizabeth E Bailey1, David F Fiorentino.   

Abstract

Amyopathic dermatomyositis can be a challenging diagnosis because patients lack traditional muscle findings. "Clinically amyopathic" dermatomyositis (CADM) accounts for the presence of subclinical muscle disease in some of these patients. These patients represent a substantial minority of dermatomyositis cases and have similar co-morbidities to "classic" dermatomyositis patients, including interstitial lung disease and malignancy. Clinically amyopathic dermatomyositis patients should not be considered as a distinct clinical entity from "classic" dermatomyositis, as they share antibody sub-types and associated co-morbidities, likely representing clinical spectrum of a common disease. It is essential for the clinician to be familiar with the clinical presentation of clinically amyopathic dermatomyositis, in order to facilitate early, accurate diagnosis and appropriate clinical management.

Entities:  

Mesh:

Year:  2014        PMID: 25366932     DOI: 10.1007/s11926-014-0465-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  28 in total

1.  Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan.

Authors:  Yoshioki Yamasaki; Hidehiro Yamada; Michiko Ohkubo; Masaomi Yamasaki; Kohei Azuma; Hitoshi Ogawa; Machiko Mizushima; Shoichi Ozaki
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

2.  Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.

Authors:  Y J Chen; C Y Wu; J L Shen
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

3.  Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.

Authors:  E H Kang; E B Lee; K C Shin; C H Im; D H Chung; S K Han; Y W Song
Journal:  Rheumatology (Oxford)       Date:  2005-06-21       Impact factor: 7.580

Review 4.  Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects.

Authors:  Richard D Sontheimer
Journal:  Dermatol Clin       Date:  2002-07       Impact factor: 3.478

5.  The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody.

Authors:  Ran Nakashima; Yoshitaka Imura; Shio Kobayashi; Naoichiro Yukawa; Hajime Yoshifuji; Takaki Nojima; Daisuke Kawabata; Koichiro Ohmura; Takashi Usui; Takao Fujii; Katsuya Okawa; Tsuneyo Mimori
Journal:  Rheumatology (Oxford)       Date:  2009-12-16       Impact factor: 7.580

6.  Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota.

Authors:  Margo J Bendewald; David A Wetter; Xujian Li; Mark D P Davis
Journal:  Arch Dermatol       Date:  2010-01

Review 7.  A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.

Authors:  Pedram Gerami; Jennifer M Schope; Lauren McDonald; Hobart W Walling; Richard D Sontheimer
Journal:  J Am Acad Dermatol       Date:  2006-01-23       Impact factor: 11.527

8.  Dermatomyositis with normal muscle enzyme concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound.

Authors:  M R Stonecipher; J L Jorizzo; J Monu; F Walker; P G Sutej
Journal:  Arch Dermatol       Date:  1994-10

Review 9.  Amyopathic dermatomyositis in Hong Kong -- association with nasopharyngeal carcinoma.

Authors:  W K Fung; H L Chan; W M Lam
Journal:  Int J Dermatol       Date:  1998-09       Impact factor: 2.736

Review 10.  Dermatologic aspects of myositis.

Authors:  R L Euwer; R D Sontheimer
Journal:  Curr Opin Rheumatol       Date:  1994-11       Impact factor: 5.006

View more
  25 in total

1.  Dermatomyositis.

Authors:  Lu Lucy Chu; Gina Rohekar
Journal:  CMAJ       Date:  2019-03-25       Impact factor: 8.262

2.  Amyotrophic dermatomyositis.

Authors:  Sundeep Shenoy; Suman Thapamagar
Journal:  CMAJ       Date:  2016-10-11       Impact factor: 8.262

3.  [Amyopathic dermatomyositis with lipoatrophy].

Authors:  Anne-Charlotte Niesert; Christoph Rothenberger; Valerie Letulé; Michael J Flaig
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

Review 4.  Diagnosis and classification of idiopathic inflammatory myopathies.

Authors:  I E Lundberg; F W Miller; A Tjärnlund; M Bottai
Journal:  J Intern Med       Date:  2016-07       Impact factor: 8.989

Review 5.  The relationship between JAK2(V617F) mutation and dermatomyositis-a case report and literature review.

Authors:  Qin Xu; Xuexiao Jin; Yu Jiang; Xin Dang; Yongmei Han
Journal:  Clin Rheumatol       Date:  2020-07-16       Impact factor: 2.980

Review 6.  Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.

Authors:  Roberta Vilela Lopes Koyama; Tiago Kiyoshi Kitabayashi Braga; George Alberto da Silva Dias; Satomi Fujihara; Hellen Thais Fuzii; Gilberto Toshimitsu Yoshikawa
Journal:  Clin Rheumatol       Date:  2017-05-09       Impact factor: 2.980

Review 7.  The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review.

Authors:  S Ahmed; K L Chen; V P Werth
Journal:  Semin Arthritis Rheum       Date:  2020-01-11       Impact factor: 5.532

Review 8.  Autoantibodies in myositis.

Authors:  Neil J McHugh; Sarah L Tansley
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

9.  The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy.

Authors:  Ya-Mei Zhang; Han-Bo Yang; Jing-Li Shi; He Chen; Xiao-Ming Shu; Xin Lu; Guo-Chun Wang; Qing-Lin Peng
Journal:  Clin Rheumatol       Date:  2018-03-15       Impact factor: 2.980

10.  Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis.

Authors:  Gulnara Mamyrova; Takayuki Kishi; Ira N Targoff; Alison Ehrlich; Rodolfo V Curiel; Lisa G Rider
Journal:  Rheumatology (Oxford)       Date:  2018-11-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.